By Freddie Allen NNPA Washington Correspondent WASHINGTON (NNPA) – A proposed rule change for generic drug labels, crafted by the Food and Drug Administration, could cost patients, health care providers and drug manufacturers billions of dollars and limit access to affordable, prescription drugs for minorities and the poor, according to more than a dozen organizations […]
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.